GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Long-Term Capital Lease Obligation

Alkermes (STU:8AK) Long-Term Capital Lease Obligation : €68 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Alkermes Long-Term Capital Lease Obligation?

Alkermes's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €68 Mil.

Alkermes's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€74 Mil) to Dec. 2023 (€69 Mil) and declined from Dec. 2023 (€69 Mil) to Mar. 2024 (€68 Mil).

Alkermes's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (€92 Mil) to Dec. 2022 (€72 Mil) and declined from Dec. 2022 (€72 Mil) to Dec. 2023 (€69 Mil).


Alkermes Long-Term Capital Lease Obligation Historical Data

The historical data trend for Alkermes's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Long-Term Capital Lease Obligation Chart

Alkermes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.81 98.20 92.18 72.02 69.43

Alkermes Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.43 76.00 73.60 69.43 68.17

Alkermes  (STU:8AK) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Alkermes Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Alkermes's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkermes (STU:8AK) Business Description

Industry
Traded in Other Exchanges
Address
1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines